Novel phenyl propionic acid derivatives and uses thereof
AssigneeIldong Pharmaceutical Co., Ltd.
InventorsJae-Hoon KANG, Hong-Sub LEE, Kyung-Mi AN, Chang-Hee HONG, Hyun-Jung KWAK, Shuo-Lin CUI, Hyo-Jung SONG
Life of this patent
Estimating the term…
Loading patent…
AssigneeIldong Pharmaceutical Co., Ltd.
InventorsJae-Hoon KANG, Hong-Sub LEE, Kyung-Mi AN, Chang-Hee HONG, Hyun-Jung KWAK, Shuo-Lin CUI, Hyo-Jung SONG
Estimating the term…
Compounds of Formula (I), racemates, enantiomers, diastereomers thereof or pharmaceutical acceptable salts thereof, or pharmaceutical compositions containing the compounds, racemates, enantiomers, diastereomers thereof are disclosed. These compounds have GPR40 agonist activity and are capable of modulating blood glucose levels and glucose-dependent insulin secretion mechanism, and, thus, exhibit excellent glucose lowering efficacy without the risk of hypoglycemia. These compounds could be used in preventing and/or treating type 2 diabetes through adequate control of blood glucose.
A compound of the following Formula (I), a racemate thereof, an enantiomer thereof, a diastereomer thereof, or a pharmaceutically acceptable salt of the compound, the racemate, the enantiomer, or the diastereomer:
Dependencies are inferred from the claim text.